Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2016
Total Assets: $52.67B
Liabilities Breakdown FY2016
Total Liabilities: $32.13B
Asset Breakdown
Total Assets: $52.67B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.62B | 35.4% |
| Accounts Receivable | $3.25B | 6.2% |
| Inventory | $2.43B | 4.6% |
| Property, Plant & Equipment | $5.71B | 10.8% |
| Goodwill | $7.68B | 14.6% |
| Intangible Assets | $4.54B | 8.6% |
| Other Assets | $10.44B | 19.8% |
Liabilities Breakdown
Total Liabilities: $32.13B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.18B | 3.7% |
| Long-Term Debt | $20.68B | 64.4% |
| Other Liabilities | $10.27B | 32.0% |